Additionally, combined targeting of NOS and PI3K reduced cell proliferation, thereby providing a two-pronged attack by reducing invasion through inhibiting EMT and decreasing the proliferation of MpBC tumor cells that may colonize metastatic sites. The gene discussed is PIK3CA; the disease is neoplasm.